Presentation – Alligator Bioscience

2023-11-09

Alligator Bioscience to Participate in Upcoming Industry Conferences in November 2023

Lund, Sweden – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that senior company representatives will participate in the fo ...

2023-11-03

Presentation highlights ATOR-4066's superior anti-tumor effect and confirms CEACAM5-conditional activation of CD40 expressing cells Dat ...

2023-10-31

Lund, Sweden – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces it will hold a Capital Markets Day on December 1, 2023. ...

2023-10-03

Lund, Sweden – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that senior company representatives will participate in the fo ...

2022-04-22

LUND (Sweden) – April 22, 2022 – Alligator Bioscience will host a conference call (in English) for investors, analysts and media on Wednesda ...

2022-02-042022-03-23

LUND (Sweden) – February 4, 2022 – Alligator Bioscience will host a conference call (in English) for investors, analysts and media on Friday ...

2021-10-15

LUND (Sweden) – Alligator Bioscience will host a conference call (in English) investors, analysts and media on Thursday, October 21st, 2021, ...

2019-02-12

Alligator Bioscience (Nasdaq Stockholm: ATORX) – On 14 February 2019, at 08:00 a.m. CET, Alligator Bioscience will publish its report ...

2018-04-05

Lund, Sweden, 5 April – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals fo ...